Locally Advanced or Metastatic Breast Cancer
Oncology
1
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
MediLink TherapeuticsChina - Suzhou
1 program1
YL202 should be intravenously infusedPhase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
MediLink TherapeuticsYL202 should be intravenously infused
EisaiEribulin mesylate
EisaiEribulin
Clinical Trials (3)
Total enrollment: 693 patients across 3 trials
A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of YL202 in Patients With BC
Start: Apr 2024Est. completion: Jul 2028
Phase 2Recruiting
A Study to Investigate the Efficacy and Safety of Eribulin in Korean Breast Cancer Participants
Start: Jan 2018Est. completion: Jun 2018340 patients
N/ACompleted
Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy
Start: Oct 2016Est. completion: May 2022353 patients
N/ACompleted
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
14m ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
14m ago
Office Administrator
SystImmune
15m ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
25m ago
Working Student Office Management Support (m/f/d)
Mindpeak
Hamburg
29m ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
29m ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 693 patients
2 companies competing in this space